Zero Revenue, Going Concern Warning for Groove Botanicals After $358K Loss
GRVE has more than doubled off its 52-week low of $0.001 on light trading volume (0.1× avg).
Summary
Groove Botanicals reported zero revenue for FY 2026, with a net loss of $358,387 and diluted EPS of $(0.01). The company's cash balance is critically low at $1,502, leading to an explicit 'going concern' warning in its 10-K filing. This severe financial distress, including no expected near-term product sales, follows an auditor resignation reported in May. Management is now pursuing a new business model and additional financing to survive.
At the time of this announcement, GRVE was trading at $0.00 on OTC in the Life Sciences sector, with a market capitalization of approximately $238.6K. The 52-week trading range was $0.00 to $0.30. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Wiseek News.